KUALA LUMPUR: Pharmaniaga Bhd’s net loss for the financial year ended Dec 31, 2023( FY2023) narrowed to RM77.45 million from RM629.92 million in FY2022. Revenue dropped to RM3.40 billion from RM3.48 billion, representing a 2.2 per cent decrease, mainly due to the reduction in revenue from its concession business as a result of a lower budget allocation. For the fourth quarter( 4Q), its net loss shrank to RM32.72 million from a loss of RM644.39 million, while revenue slid to RM789.81 million from
综合
星报-商业
2024-02-29 00:00:00.0